--- title: "Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting | BCYC Stock News" type: "News" locale: "en" url: "https://longbridge.com/en/news/287272414.md" description: "Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting | BCYC Stock News" datetime: "2026-05-21T13:00:28.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287272414.md) - [en](https://longbridge.com/en/news/287272414.md) - [zh-HK](https://longbridge.com/zh-HK/news/287272414.md) --- # Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting | BCYC Stock News Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting | BCYC Stock News ### Related Stocks - [BCYC.US](https://longbridge.com/en/quote/BCYC.US.md) ## Related News & Research - [Bicycle Therapeutics presents initial Duravelo-2 data showing comparable ORR and lower toxicity in mUC](https://longbridge.com/en/news/287274269.md) - [Bicycle Therapeutics (NASDAQ:BCYC) Issues Quarterly Earnings Results](https://longbridge.com/en/news/279422088.md) - [Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?](https://longbridge.com/en/news/288948995.md) - [](https://longbridge.com/en/news/288700390.md) - [ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026 | TLX Stock News](https://longbridge.com/en/news/288327814.md)